Comments
Loading...
Guidance e previsioni
Vertex Pharmaceuticals fornisce indicazioni su EPS e ricavi futuri, offrendo agli investitori informazioni su quanto la società prevede di guadagnare nei prossimi periodi.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/04/2025 | VRTX | Vertex Pharmaceuticals | FY | 2025 | — | — | — | $11.85B | $12.00B | $11.93B | |
05/05/2025 | VRTX | Vertex Pharmaceuticals | FY | 2025 | — | — | — | $11.85B | $12.00B | $11.98B | |
02/10/2025 | VRTX | Vertex Pharmaceuticals | FY | 2025 | — | — | — | $11.75B | $12.00B | $11.85B | |
11/04/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.80B | $10.90B | $10.75B | |
08/01/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.65B | $10.85B | $10.76B | |
05/06/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.55B | $10.75B | $10.70B | |
02/05/2024 | VRTX | Vertex Pharmaceuticals | FY | 2024 | — | — | — | $10.55B | $10.75B | $10.61B | |
11/06/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.85B | $9.85B | $9.87B | |
08/01/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.70B | $9.80B | $9.75B | |
05/01/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.55B | $9.70B | $9.71B | |
02/07/2023 | VRTX | Vertex Pharmaceuticals | FY | 2023 | — | — | — | $9.55B | $9.70B | $9.60B | |
10/27/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.80B | $8.90B | $8.77B | |
08/04/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.60B | $8.80B | $8.58B | |
05/05/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.40B | $8.60B | $8.58B | |
01/26/2022 | VRTX | Vertex Pharmaceuticals | FY | 2022 | — | — | — | $8.40B | $8.60B | $8.22B | |
11/02/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $7.40B | $7.50B | $7.32B | |
07/29/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $7.20B | $7.40B | $6.99B | |
04/29/2021 | VRTX | Vertex Pharmaceuticals | FY | 2021 | — | — | — | $6.70B | $6.90B | $6.95B | |
01/11/2021 | VRTX | Vertex Pharmaceuticals | FY | 2020 | — | — | — | $6.00B | $6.20B | $6.14B |
FAQ
Qual è la guidance più recente per Vertex Pharmaceuticals (VRTX)?
Negli ultimi mesi non sono state riportate guidance specifiche sulle vendite o sugli utili di Vertex Pharmaceuticals.
Sfoglia guidance e previsioni su tutte le azioni.